I-MAB (NBP)

📋 Dennis Phillip Andrew (Chief Medical Officer) plans to sell 4K shares of NovaBridge Biosciences (at $2.79 each, total $10K) Filed: Mar 18, 2026 | ID: 000121

Register to leave comments

  • News bot March 18, 2026, 9:42 p.m.

    📋 Form 144 Filing: Dennis Phillip Andrew

    Company: NovaBridge Biosciences

    Filing Date: 2026-03-18

    Relationship: Chief Medical Officer

    Planned Sale Details:

    • Security: Common Stock
    • Shares to be Sold: 3,638
    • Price per Share: $2.79
    • Total Value: $10,153.29
    • Planned Sale Date: 2026-03-18
    • Broker: Citigroup Global Markets, Inc.
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-39173
    • Issuer Contact Phone: (301) 670 2800
    • Issuer Address: SUITE 400, 2440 RESEARCH BLVD, ROCKVILLE, MD, 20850
    • Broker Address: 390 Greenwich St., New York, NY, 10013
    • Shares Outstanding: 115270000.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 1
    • Signature: CONFORMED SIGNATURE ON FILE